Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.42 |
| ▸ | CES1 | P23141 | 3/20 | 0.42 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | DAO | P14920 | 1/20 | 0.38 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | AKT1 | P31749 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28432141 | 0.86 | SMN1; SMN2 (0.54) | ALDH1A1MAPTL3MBTL1SMN1; SMN2 | |
| SCHEMBL28126867 | 0.76 | CES2 (0.44) | CES2CES1ALDH1A1TSHRDAO | |
| SCHEMBL3846147 | 0.76 | CES2 (0.44) | CES2CES1ALDH1A1TSHRDAO | |
| SCHEMBL9194201 | 0.76 | CES2 (0.44) | CES2CES1ALDH1A1TSHRDAO | |
| SCHEMBL701017 | 0.76 | CES2 (0.44) | CES2CES1ALDH1A1TSHRDAO | |
| SCHEMBL8234469 | 0.75 | CYP19A1 (0.48) | MAOAALDH1A1TSHRMAPTESR1 | |
| SCHEMBL5828005 | 0.74 | CES1 (0.48) | CES2CES1ALDH1A1TSHRDAO | |
| SCHEMBL15656328 | 0.74 | CES2 (0.42) | CES2CES1ALDH1A1TSHRDAO | |
| SCHEMBL28170573 | 0.74 | CES2 (0.42) | CES2CES1ALDH1A1TSHRDAO | |
| SCHEMBL28835292 | 0.74 | CES2 (0.42) | CES2CES1MAOAMAOBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10920004-B2 | Method for preparing modified conjugated diene-based polymer | LG CHEM, LTD. | 2021-02-16 | — | — | US | claimed |
| US-10882939-B2 | — | — | 2021-01-05 | — | — | US | claimed |
| US-20190256635-A1 | Method for Preparing Modified Conjugated Diene-based Polymer | LG CHEM, LTD. (KR) | 2019-08-22 | — | — | US | claimed |
| EP-3473654-B1 | METHOD FOR PREPARING MODIFIED CONJUGATED DIENE-BASED POLYMER, AND MODIFIED CONJUGATED DIENE-BASED POLYMER PREPARED BY USING SAME | LG CHEMICAL LTD (KR) | 2022-04-20 | — | — | EP | disclosed |
| EP-3792291-B1 | METHOD FOR PREPARING MODIFIED CONJUGATED DIENE-BASED POLYMER | LG CHEMICAL LTD (KR) | 2022-03-16 | — | — | EP | disclosed |
| EP-3792291-A1 | METHOD FOR PREPARING MODIFIED CONJUGATED DIENE-BASED POLYMER | LG CHEM, LTD. (KR) | 2021-03-17 | — | — | EP | disclosed |
| CN-112480835-A | Adhesive sheet | 日本电石工业株式会社 | 2021-03-12 | — | — | CN | disclosed |
| US-10920004-B2 | Method for preparing modified conjugated diene-based polymer | LG CHEM, LTD. | 2021-02-16 | — | — | US | disclosed |
| EP-3511350-B1 | METHOD FOR PREPARING MODIFIED CONJUGATED DIENE-BASED POLYMER | LG CHEMICAL LTD (KR) | 2021-01-27 | — | — | EP | disclosed |
| US-10882939-B2 | — | — | 2021-01-05 | — | — | US | disclosed |
| CN-209496895-U | The encapsulating structure and light source of composite fluorescence glue film, semiconductor light-emitting apparatus | 弗洛里光电材料（苏州）有限公司 | 2019-10-15 | — | — | CN | disclosed |
| US-20100277063-A1 | FLUORENE-BASED DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2010-11-04 | — | — | US | disclosed |
| US-7781628-B2 | Fluorene-based derivative and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2010-08-24 | — | — | US | disclosed |
| US-20100210661-A1 | STAT3/5 ACTIVATION INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2010-08-19 | — | — | US | disclosed |
| US-7683225-B2 | Fluorene-based derivative and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2010-03-23 | — | — | US | disclosed |
| US-20100004438-A1 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2010-01-07 | — | — | US | disclosed |
| US-20080303433-A1 | FLUORENE-BASED DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-11 | — | — | US | disclosed |
| US-20070270422-A1 | Aromatic Compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-11-22 | — | — | US | disclosed |
| EP-1780191-A1 | FLUORENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2007-05-02 | — | — | EP | disclosed |
| US-20060159956-A1 | Fluorene-based derivative and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100277063-A1 | FLUORENE-BASED DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | LEF1, FLNA, AFF2 | CES2 330/4885CES1 2129/4885MAOA 83/4885 |
| US-20080303433-A1 | FLUORENE-BASED DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | FLNA, AFF2, LEF1 | CES2 491/4885CES1 2433/4885MAOA 105/4885 |
| US-20100210661-A1 | STAT3/5 ACTIVATION INHIBITOR | STAT3, JAK2, STAT1 | CES2 3247/4885CES1 2557/4885MAOA 3260/4885 |
| US-20100004438-A1 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | ROS1, CBR1, CBR3 | CES2 2426/4885CES1 447/4885MAOA 3148/4885 |
| US-20070270422-A1 | Aromatic Compounds | COL1A1, COL2A1, COL14A1 | CES2 1853/4885CES1 921/4885MAOA 317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.